IMCR
Immunocore AmericanFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
IMCR vs peer average
34/100
IMCR vs. peer average (F vs. D)
Grade spread
B 1 · C 1 · D 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
GENB is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.59B
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMCR
Immunocore American
GENB
Generate Biomedicines
Grade
F
B
Momentum
31
9
Value
41
46
Sentiment
-
77
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs GENB
IMCR / GENB
Grade Position
Below peers
IMCR vs. peer average (F vs. D)
34/100
Momentum
31
IMCRValue
41
GENBSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMCR
GENB is the first peer returned for this comparison set.